MAP Pharmaceuticals Announces Termination of Pediatric Asthma Collaboration

Full story: Pharmaceutical Processing

MAP Pharmaceuticals, Inc. has announced that it has received a notice of termination of the license agreement with AstraZeneca related to the company's Unit Dose Budesonide product candidate.

Leave a Comment

Comments

Type in your comments to post to the forum

Name
(appears on your post)

Comments

Type the numbers you see in the image on the right:

Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Other Recent Asthma Discussions

Topic	Updated	Last By	Comments
A Novel Gene Found For Childhood-Onset Asthma	Dec 30	Stephany McD...	1
Can Singulair Cause Depression? (Nov '08)	Dec 28	mark	11
air quality monitoring equipment	Dec 24	John N	1
asthma update	Dec 21	JessiBrown	2
Number of kids in daycare may affect asthma risk	Dec 21	Jessibrown	1
Arrowhead Regional to expand Breathmobileservic...	Dec 18	Motorhome com	1
Swine Flu Claims The Life Of Waco-Area Elementa...	Dec 15	Bolins Friend	1